TVGN

Tevogen Bio Holdings Inc.

TVGN · CIK 1860871 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$14M
20212024
Operating CF−$12M
20212024
Free Cash Flow−$12M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B———
SG&A Expense————
Operating Income$-0.1B———
Net Income$-0.0B$-0.0B$0.0B$-0.0B
EPS (Basic)$-0.07———
EPS (Diluted)$-0.07———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.4B$0.4B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$-0.0B$-0.0B$-0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$0.3B$-0.4B$-0.4B
Capital Expenditures$0.0B———
Financing Cash Flow$0.0B$-0.3B$0.4B$0.4B
← Companies